REZZAYO (rezafungin for injection)

Rezzayo is an antifungal medicine used to treat adults with invasive candidiasis. Invasive candidiasis is a fungal infection caused by a yeast called Candida that has spread widely in the body and may also be present in the blood.

Home | rezafungin for injection

REZZAYO (rezafungin for injection) Price In India Ahmedabad Bengaluru Chennai Kolkata Mumbai
REZZAYO (rezafungin for injection)

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

REZZAYO (rezafungin for injection)

Rezzayo, is a medication used for the treatment of invasive candidiasis. It is an echinocandin antifungal.

REZZAYO is an echinocandin antifungal indicated in patients 18 years of age or older who have limited or no alternative options for the treatment of candidemia and invasive candidiasis.

Rezafungin, sold under the brand name Rezzayo, is a medication used for the treatment of invasive candidiasis. It is an echinocandin antifungal. Rezafungin was approved for medical use in the United States in March 2023, and in the European Union in December 2023.

Drug (Brand / Generic): REZZAYO /rezafungin
Current Indication: treat Skin Cancer
Approval Date: 2023

ACOVAÔ (argatroban) Injection is supplied in 2.5 mL solution in single-use vials at the concentration of 100 mg/mL. Each vial contains 250 mg of argatroban.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.